Literature DB >> 3398430

[Comparison of the hemodynamics effects of D-sotalol and D,L-sotalol].

H M Hoffmeister1, L Seipel.   

Abstract

The hemodynamic effects of the class III drug D-sotalol and of the beta adrenergic receptor antagonist D,L-sotalol were compared in 16 rats (2 mg/kg i.v.). A group with NaCl-infusion served as control (n = 10). Besides measurements in the intact circulation isovolumic registrations were performed to examine the left ventricular myocardial function without interferences. D,L-sotalol significantly reduced the dp/dtmax (61%) and the peak isovolumic left ventricular pressure (64%). It lowered the heart rate by 13% and slightly increased the mean aortic pressure to 107% (p less than 0.05). D-sotalol, in contrast, caused only a very transient reduction of the dp/dtmax and was comparable to the controls already 5 min after injection. The results demonstrate, that the D-enantiomer is largely avoid of the hemodynamic effects of the racemic D,L-sotalol after intravenous injection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3398430     DOI: 10.1007/bf01745517

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

1.  [Experimental studies of the hemodynamics of disopyramide in comparison with quinidine].

Authors:  H M Hoffmeister; A Hepp; L Seipel
Journal:  Z Kardiol       Date:  1988-01

2.  Antiarrhythmic activity of the dextro- and levorotatory isomers of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999).

Authors:  P Somani; D L Watson
Journal:  J Pharmacol Exp Ther       Date:  1968-12       Impact factor: 4.030

3.  Left ventricular hypertrophy and pressure generating capacity in aging genetically hypertensive rats.

Authors:  M A Pfeffer; J M Pfeffer
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

4.  Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol.

Authors:  E Patterson; J J Lynch; B R Lucchesi
Journal:  J Pharmacol Exp Ther       Date:  1984-08       Impact factor: 4.030

5.  Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol.

Authors:  J J Lynch; D J Wilber; D G Montgomery; T M Hsieh; E Patterson; B R Lucchesi
Journal:  J Cardiovasc Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.105

6.  Electrophysiologic effects of d-sotalol in humans.

Authors:  J M McComb; B McGovern; J B McGowan; J N Ruskin; H Garan
Journal:  J Am Coll Cardiol       Date:  1987-07       Impact factor: 24.094

7.  Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties.

Authors:  P Touboul; G Atallah; G Kirkorian; M Lamaud; P Moleur
Journal:  Am Heart J       Date:  1984-05       Impact factor: 4.749

8.  Myocardial and circulatory effects of inosine.

Authors:  H M Hoffmeister; R Betz; H Fiechtner; L Seipel
Journal:  Cardiovasc Res       Date:  1987-01       Impact factor: 10.787

9.  Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death.

Authors:  J J Lynch; L A Coskey; D G Montgomery; B R Lucchesi
Journal:  Am Heart J       Date:  1985-05       Impact factor: 4.749

10.  Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol.

Authors:  B S Manley; D Alexopoulos; G J Robinson; S M Cobbe
Journal:  Cardiovasc Res       Date:  1986-10       Impact factor: 10.787

View more
  2 in total

1.  Hemodynamic effects of the D- and L-isomers of sotalol on normal myocardium.

Authors:  H M Hoffmeister; M Beyer; L Seipel
Journal:  Cardiovasc Drugs Ther       Date:  1991-12       Impact factor: 3.727

Review 2.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.